Literature DB >> 17373561

Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders.

Sandra A Brown1, Suzette V Glasner-Edwards, Susan R Tate, John R McQuaid, John Chalekian, Eric Granholm.   

Abstract

In a randomized trial, this study compared the longitudinal outcome patterns of veterans (N = 66) with substance use disorders and major depressive disorder receiving standard pharmacotherapy and either 12-Step Facilitation Therapy (TSF) or disorder-specific Integrated Cognitive Behavioral Treatment (ICBT). Depression and substance use were assessed at intake, during and after treatment using the Hamilton Depression Rating Scale and the Time Line Follow Back. Reductions in depression during treatment were comparable between the two treatment groups; however, their posttreatment patterns were distinct. While ICBT participants evidenced a steady linear decline in depression through six months posttreatment, a quadratic trend characterized TSF participants, for whom depression declined during treatment, but increased throughout posttreatment follow-up. During treatment, TSF participants used substances less frequently relative to those in ICBT; however, reductions in substance use were more stable through six months posttreatment among those in ICBT relative toTSF. While both interventions produced improvement in depression and substance use during treatment, ICBT may yield more stable clinical outcomes once treatment ceases.

Entities:  

Mesh:

Year:  2006        PMID: 17373561     DOI: 10.1080/02791072.2006.10400584

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  23 in total

1.  Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain?

Authors:  Judson A Brewer; Sarah Bowen; Joseph T Smith; G Alan Marlatt; Marc N Potenza
Journal:  Addiction       Date:  2010-10       Impact factor: 6.526

Review 2.  Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature.

Authors:  Morten Hesse
Journal:  BMC Psychiatry       Date:  2009-02-20       Impact factor: 3.630

3.  Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Authors:  Susan M Paddock; Sarah B Hunter; Thomas J Leininger
Journal:  J Subst Abuse Treat       Date:  2014-03-01

Review 4.  12-step participation among dually-diagnosed individuals: a review of individual and contextual factors.

Authors:  Darrin M Aase; Leonard A Jason; W LaVome Robinson
Journal:  Clin Psychol Rev       Date:  2008-05-13

5.  Treatment Engagement: Female Survivors of Intimate Partner Violence in Treatment for PTSD and Alcohol Use Disorder.

Authors:  Ursula S Myers; Kendall C Browne; Sonya B Norman
Journal:  J Dual Diagn       Date:  2015

6.  Service utilization during and after outpatient treatment for comorbid substance use disorder and depression.

Authors:  Matthew J Worley; Ryan S Trim; Susan R Tate; Jessica E Hall; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2010-07-03

7.  Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression.

Authors:  Matthew J Worley; Susan R Tate; Eric Granholm; Sandra A Brown
Journal:  J Consult Clin Psychol       Date:  2014-03-03

8.  12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model.

Authors:  Matthew J Worley; Susan R Tate; John R McQuaid; Eric L Granholm; Sandra A Brown
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

Review 9.  Treatment of the depressed alcoholic patient.

Authors:  Jeffrey J DeVido; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

10.  Does initial treatment focus influence outcomes for depressed substance abusers?

Authors:  Michelle L Drapkin; Susan R Tate; John R McQuaid; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2008-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.